0,1
"Table 3:  Prognostic-based staging system for metastatic germ cell cancer (IGCCCG) [42, 43]*",
Good-prognosis group,
Non-seminoma  5-year PFS 90%  5-year survival 96%,"All of the following criteria:  • Testis/retro-peritoneal primary  • No non-pulmonary visceral metastases  • AFP < 1,000 ng/mL  • hCG < 5,000 IU/L (1,000 ng/mL)  • LDH < 1.5 x ULN"
Seminoma  5-year PFS 89%  5-year survival 95%,All of the following criteria:  • Any primary site  • No non-pulmonary visceral metastases  • Normal AFP  • Any hCG  • Any LDH
Intermediate-prognosis group,
Non-seminoma  5-year PFS 78%  5-year survival 89%,"• Testis/retro-peritoneal primary  • No non-pulmonary visceral metastases  And any of the following criteria:  • AFP 1,000 - 10,000 ng/mL or  • hCG 5,000 - 50,000 IU/L or  • LDH 1.5 - 10 x ULN"
Seminoma  5-year PFS 79%  5-year survival 88%,All of the following criteria:  • Any primary site  • Non-pulmonary visceral metastases  • Normal AFP  • Any hCG  • Any LDH
Poor-prognosis group,
Non-seminoma  5-year PFS 54%  5-year survival 67%,"Any of the following criteria:  • Mediastinal primary  • Non-pulmonary visceral metastases  • AFP > 10,000 ng/mL or  • hCG > 50,000 IU/L (10,000 ng/mL) or  • LDH > 10 x ULN"
Seminoma,No patients classified as “poor-prognosis”
